Gupta and collaborators demonstrated that a combination cocktail of drugs targeting KIT/PI3K/MAPK with sunitinib or regorafenib can induce apoptosis in a GIST cell line established from an untreated GIST harboring an IM-sensitive, KIT primary mutation [178]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.